The answer to how often you should inject Retatrutide is clear: once weekly
Retatrutide, also known as LY3437943, is an investigational synthetic peptide
Clinical trials with IDegLira Insulin naive patients In the DUAL-1 trial [19], 1663 insulin-naive patients with T2DM in use of metformin and/or pioglitazone were randomized to receive IDeglira, insulin degludec or liraglutide for 26 weeks
GLP-1s: Beyond weight loss and diabetes Unlocking their potential for myriad chronic conditions Semaglutide and tirzepatide, the active ingredients in such medications as Ozempic/Wegovy and Mounjaro/Zepbound, have been proven to improve metabolic health
Conversely, the use of liraglutide in the LEADER trial led to a 22% reduction in cardiovascular deaths [53, 54, 56]